Related Experiment Video
Updated: Mar 10, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Domain-Specific Monoclonal Antibodies Against Human Rev-erbβ
Fang Chen1,2, Yanqing Li1, Junli Zhao1
1Laboratory of Gene Therapy, Department of Biochemistry, College of Life Sciences, Shaanxi Normal University, 199 South Chang'an Road, Xi'an, 710062, Shaanxi, People's Republic of China.
Abstract:
The nuclear receptor Rev-erbβ is a potent transcriptional factor whose functional study has been limited by the lack of suitable antibodies against it. To better understand Rev-erbβ's biological roles, we generated five hybridoma cell lines secreting antibodies against human Rev-erbβ in mice immunized with the purified, prokaryotically expressed recombinant Rev-erbβ-6His fusion protein. Using Western blotting and immunofluorescence analyses, all the five monoclonal antibodies (MAbs) showed strong immunoreactivity to both prokaryotically and eukaryotically expressed recombinant Rev-erbβ. An immunoprecipitation study showed that all five monoclonal antibodies against Rev-erbβ were able to pull down the recombinant Rev-erbβ-Flag protein, but only one of the MAbs against Rev-erbβ, 37H8, could pull down the endogenous Rev-erbβ protein. Furthermore, domain specificity of these MAbs was characterized. Due to the high similarities between Rev-erbα and Rev-erbβ in the C and E domains, those C and E domain-specific anti-Rev-erbβ antibodies can react with human Rev-erbα as well. The MAbs produced in the study will provide a valuable tool for investigating the function of Rev-erbβ.
Insights
Researchers developed five new monoclonal antibodies (MAbs) targeting the Rev-erbβ nuclear receptor. One MAb, 37H8, successfully detected endogenous Rev-erbβ, enabling functional studies of this important transcriptional factor.
Area of Science:
- Molecular Biology
- Immunology
- Gene Regulation
Background:
- The nuclear receptor Rev-erbβ is a critical transcriptional factor.
- Functional studies of Rev-erbβ have been hindered by the absence of specific antibodies.
Purpose of the Study:
- To generate and characterize monoclonal antibodies (MAbs) against human Rev-erbβ.
- To develop tools for investigating the biological roles of Rev-erbβ.
Main Methods:
- Immunization of mice with purified recombinant human Rev-erbβ-6His fusion protein.
- Generation of hybridoma cell lines secreting anti-Rev-erbβ MAbs.
- Western blotting, immunofluorescence, and immunoprecipitation assays to assess antibody reactivity and specificity.
Main Results:
- Five hybridoma cell lines producing anti-Rev-erbβ MAbs were successfully generated.
- All five MAbs demonstrated strong immunoreactivity against recombinant Rev-erbβ.
- One MAb, 37H8, exhibited the ability to immunoprecipitate endogenous Rev-erbβ.
- Antibody cross-reactivity with Rev-erbα was observed for antibodies specific to shared C and E domains.
Conclusions:
- The developed MAbs are valuable tools for studying Rev-erbβ.
- The MAb 37H8 is particularly useful for detecting endogenous Rev-erbβ.
- These antibodies will facilitate further research into Rev-erbβ's functions in biological systems.
More Related Videos
13:21Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Related Concept Videos
Cross-reactivity
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...